ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

PROK Company Profile and Key Details

NASDAQ : PROK

ProKidney Corp.

$0.84

0.0097+1.17%

At Close 4:00 PM

75.78

B+ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

PROK Stock Price Chart

Stock Price Today

ProKidney Corp. (PROK) stock surged +1.17%, trading at $0.84 on NASDAQ, up from the previous close of $0.83. The stock opened at $0.82, fluctuating between $0.80 and $0.86 in the recent session.

Stock Snapshot

0.83

Prev. Close

0.82

Open

245.78M

Market Cap

292.7M

Number of Shares

0.8

Day Low

0.8629

Day High

-1.35

P/E Ratio

71.82%

Free Float in %

-0.62

EPS (TTM)

-18.43

Book Value

-2.08

Cash Flow per Share

649.93K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2025	0.82	0.89	0.80	0.84	649.99K
Apr 01, 2025	0.86	0.91	0.83	0.83	1.06M
Mar 31, 2025	0.91	1.00	0.86	0.88	362.57K
Mar 28, 2025	0.95	0.99	0.89	0.91	403.31K
Mar 27, 2025	0.95	1.00	0.90	0.94	298.17K
Mar 26, 2025	1.01	1.02	0.94	0.94	287.1K
Mar 25, 2025	1.04	1.06	0.99	1.01	241.4K
Mar 24, 2025	1.00	1.05	0.99	1.02	240.8K
Mar 21, 2025	0.94	1.03	0.87	0.96	824.6K
Mar 20, 2025	0.99	1.03	0.93	0.95	256.52K
Mar 19, 2025	1.00	1.04	0.95	0.99	191.2K
Mar 18, 2025	1.03	1.05	0.95	0.97	470.94K
Mar 17, 2025	0.97	1.07	0.97	1.04	240.71K
Mar 14, 2025	0.98	1.07	0.94	0.98	480.73K
Mar 13, 2025	0.99	1.03	0.94	0.95	490.83K
Mar 12, 2025	1.02	1.06	0.99	1.00	767.67K
Mar 11, 2025	0.99	1.06	0.95	1.05	252.02K
Mar 10, 2025	1.02	1.06	0.94	0.98	415.76K
Mar 07, 2025	1.06	1.08	1.01	1.05	281.43K
Mar 06, 2025	1.04	1.05	1.00	1.04	960.34K

Contact Details

Winston-Salem, NC 27103

United States

Website: https://www.prokidney.comContact: 336 999 7028

About Company

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Frequently Asked Questions

What is the current ProKidney Corp. (PROK) stock price?

ProKidney Corp. (NASDAQ: PROK) stock price is $0.84 in the last trading session. During the trading session, PROK stock reached the peak price of $0.86 while $0.80 was the lowest point it dropped to. The percentage change in PROK stock occurred in the recent session was 1.17% while the dollar amount for the price change in PROK stock was $0.01.

PROK's industry and sector of operation?

The NASDAQ listed PROK is part of Biotechnology industry that operates in the broader Healthcare sector. ProKidney Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PROK?

Mr. Timothy Lutz
Senior Vice President of Manufacturing
Dr. Libbie P. McKenzie M.D.
Chief Medical Officer
Ms. Mary Weger
Chief People Officer
Dr. Timothy A. Bertram D.V.M., Ph.D.
Founder, Chief Executive Officer & Director
Ms. Ashley H. Johns
Senior Vice President of Clinical Operations
Dr. Joseph M. Stavas M.D.
Senior Vice President of Clinical Devel.
Dr. Darin J. Weber Ph.D.
Chief Reg. Off, SVice President and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access
Dr. Kerry Cooper M.D.
Senior Vice President of Medical Affairs
Dr. Deepak Jain Ph.D.
Chief Operating Officer
Mr. James Coulston CPA
Chief Financial Officer
Mr. James Coulston C.P.A.
Chief Financial Officer
Mr. Todd C. Girolamo Esq., J.D., M.B.A.
Chief Legal Officer & Corporation Sec.
Dr. Joseph M. Stavas M.D., M.P.H.
Senior Vice President and Head of Global Clinical Devel. & Interventional Procedures
Dr. Bruce Culleton M.D.
Executive Vice President of Clinical Devel. & Commercialization
Dr. Glenn Schulman M.P.H., Pharm. D., Pharm.D.
Vice President of Investor Relations & Corporation Communications

How PROK did perform over past 52-week?

PROK's closing price is 4.96% higher than its 52-week low of $0.80 where as its distance from 52-week high of $4.44 is -81.09%.

How many employees does PROK have?

Number of PROK employees currently stands at 204.

Link for PROK official website?

Official Website of PROK is: https://www.prokidney.com

How do I contact PROK?

PROK could be contacted at phone 336 999 7028 and can also be accessed through its website. PROK operates from 2000 Frontis Plaza Blvd., Winston-Salem, NC 27103, United States.

How many shares of PROK are traded daily?

PROK stock volume for the day was 649.93K shares. The average number of PROK shares traded daily for last 3 months was 466.32K.

What is the market cap of PROK currently?

The market value of PROK currently stands at $245.78M with its latest stock price at $0.84 and 292.7M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	204
Beta	1.48
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology